Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
NWO Stevinpremie voor neuroloog Bas Bloem
jun 2022 | Bewegingsstoornissen